Article
IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism
26 Jun 2020
Abstract excerpt
BACKGROUND: Research evidence accumulated in the past years in both rodent and human models for autism spectrum disorders (ASD) have established insulin-like growth factor 1 (IGF-1) as one of the most promising ASD therapeutic interventions to date. ASD is phenotypically and etiologically heterogeneous, making it challenging to uncover the underlying genetic and cellular pathophysiology of the condition; and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
